Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
Authors:
- Kenneth H. MayerKMKenneth H. Mayer
- Michael P. DubéMDMichael P. Dubé
Open Access
- 15 November 2000
- journal article
- guideline
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (5) , 1216-1224
Abstract
Dyslipidemia is a prevalent condition that affects patients infected with human immunodeficiency virus (HIV) who are receiving antiretroviral therapyKeywords
This publication has 58 references indexed in Scilit:
- EFFICACY AND MUSCLE SAFETY OF FLUVASTATIN IN CYCLOSPORINE-TREATED CARDIAC AND RENAL TRANSPLANT RECIPIENTSTransplantation, 1998
- Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levelsAmerican Heart Journal, 1998
- Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalitiesThe Lancet, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- EditorialThe American Journal of Cardiology, 1998
- Rational Assessment of the Interaction Profile of Cerivastatin Supports its Low Propensity for Drug InteractionsDrugs, 1998
- Micronised FenofibrateDrugs, 1997
- Effects of Dietary n-3 Fatty Acid Supplementation in Men with Weight Loss Associated with the Acquired Immune Deficiency Syndrome: Relation to Indices of Cytokine ProductionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Outcome in Systemic Lupus ErythematosusMedicine, 1989